Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy

PURPOSE: The ICRU 89 recommends reporting a set of vaginal dose points for cervical cancer treatments in order to quantify the goodness of implant. This vaginal dose reporting method for combined external beam radiotherapy and brachytherapy has been adopted by the EMBRACE II study protocol. Large va...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco, Nuria, Chimeno, Jose, Adrià-Mora, Mar, Pérez-Calatayud, María José, Ibáñez, Blanca, Carmona, Vicente, Celada, Francisco, Gimeno, Jose, Lliso, Françoise, Pérez-Calatayud, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207226/
https://www.ncbi.nlm.nih.gov/pubmed/32395138
http://dx.doi.org/10.5114/jcb.2020.94494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207226/
https://www.ncbi.nlm.nih.gov/pubmed/32395138
http://dx.doi.org/10.5114/jcb.2020.94494

Ejemplares similares